The WARD project is thankful for the support of the following collaborators and foundations
Innovationsfonden
Innovation Fund Denmark
Novo Nordisk Fonden
Novo Nordisk Foundation
BetaHealth
Tværspuljen
Danske Regioner
Danish Regions
Digitaliseringsstyrelsen
Agency for Digitisation
Helsefonden
Region Hovedstaden
Capital Region of Denmark
Steno Diabetes Centre Danmark
Copenhagen Centre for Health Technology
Kræftens Bekæmpelse
The Danish Cancer Society
Bispebjerg og Frederiksberg Hospital
DTU Sundhedsteknologi
DTU Health Tech
Rigshospitalet
Radiometer
A.P. Møller Fonden
The A.P. Møller Foundation
Institut for Klinisk Medicin
Department of Clinical Medicine
The WARD founders have created a start-up company, WARD24/7 ApS, with the aim of pursuing the regulatory and commercial activities of the WARD-project (Wireless Assessment of Respiratory and circulatory Distress, a project developing a clinical support system for continuous wireless monitoring of vital signs). WARD24/7 ApS has obtained license agreement for any WARD-project software and patents. One patent has been filed: “Wireless Assessment of Respiratory and circulatory Distress (WARD)– Clinical Support System (CSS) – an automated clinical support system to improve patient safety and outcomes
Please see the regulatory and commercial homepage: WARD247.com